Radiation, endocrine therapy show fewer long-term effects
New meta-analysis helps resolve the controversy
ASCO panels provide evidence-based recommendations
New treatment option for pre-treated patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Immune and genetic biomarkers predict response rates
Clinical approaches in the era of targeted therapy
Becomes standard of care for this patient population
Can preoperative chemotherapy improve overall survival?
More prescriptive system not a concern if patients benefit
Patient input, clinical trials access are important program components
Advertisement
Advertisement